Mohamed Boutjdir Selected Research

SS-A antigen (Ro antigen)

11/2016	Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.
7/2015	Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamed Boutjdir Research Topics

Disease

10	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2005
10	Long QT Syndrome 01/2021 - 01/2016
9	Inflammation (Inflammations) 01/2022 - 11/2017
7	Torsades de Pointes (Torsade de Pointes) 01/2021 - 04/2016
5	COVID-19 01/2022 - 01/2020
5	Cardiac Arrhythmias (Arrythmia) 01/2022 - 10/2006
5	Congenital heart block 08/2013 - 08/2002
4	Atrioventricular Block 01/2022 - 08/2011
4	Heart Arrest (Cardiac Arrest) 01/2021 - 09/2017
4	Channelopathies 01/2021 - 11/2015
3	Infections 01/2022 - 11/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2013
3	Atrial Remodeling 01/2020 - 01/2017
3	Heart Failure 01/2020 - 02/2004
3	Insulin Resistance 01/2018 - 01/2013
3	Obesity 01/2018 - 01/2016
3	Bradycardia 08/2011 - 03/2004
3	Ischemia 05/2007 - 01/2005
2	Myotonic Dystrophy (Dystrophia Myotonica) 01/2022 - 01/2021
2	Ventricular Tachycardia 01/2021 - 01/2018
2	Stroke (Strokes) 01/2020 - 01/2019
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019 - 01/2015
2	Hyperglycemia 01/2018 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 01/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2007 - 10/2006
1	Cytokine Release Syndrome 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Cardiotoxicity 01/2021
1	Stable Angina 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Sick Sinus Syndrome 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Rheumatoid Arthritis 11/2017
1	Necrosis 11/2017
1	Tachycardia (Tachyarrhythmias) 09/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Atrial Fibrillation 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Connective Tissue Diseases (Connective Tissue Disease) 11/2016

Drug/Important Bio-Agent (IBA)

8	AutoantibodiesIBA 01/2022 - 03/2010
8	AntibodiesIBA 01/2021 - 08/2002
7	CytokinesIBA 01/2022 - 01/2017
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2017
6	Ion Channels (Ion Channel)IBA 01/2021 - 01/2017
4	C-Reactive ProteinIBA 01/2022 - 11/2017
4	Potassium Channels (Potassium Channel)IBA 01/2021 - 01/2016
3	CalciumIBA 01/2021 - 01/2005
3	Immunoglobulin G (IgG)IBA 07/2015 - 03/2004
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2022
2	Anti-Idiotypic AntibodiesIBA 01/2021 - 04/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 11/2015
2	Ether (Diethyl Ether)IBA 01/2021 - 11/2016
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 11/2014
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	SS-A antibodiesIBA 11/2016 - 04/2015
2	SS-A antigen (Ro antigen)IBA 11/2016 - 07/2015
2	CholesterolIBA 01/2016 - 11/2014
2	Protein Kinase CIBA 05/2007 - 10/2006
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Anti-Arrhythmia AgentsIBA 01/2022
1	AutoantigensIBA 01/2022
1	CytosineIBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2022
1	GuanineIBA 01/2022
1	LigandsIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	ThymineIBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	3' Untranslated Regions (3' UTR)IBA 01/2022
1	Connexin 43 (Connexin43)IBA 11/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Histamine Antagonists (Antihistamines)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AntigensIBA 01/2021
1	AndrogensIBA 01/2020
1	IvabradineIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	ConnexinsIBA 01/2019
1	Calcium Channels (Calcium Channel)IBA 01/2019
1	RolipramIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	Interleukin-1 (Interleukin 1)IBA 11/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	ImmunosorbentsIBA 11/2016
1	EnzymesIBA 11/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2006
2	Drug Therapy (Chemotherapy) 01/2022 - 11/2015